Jacob deGrom, the star pitcher for the Texas Rangers, underwent Tommy John surgery on Monday, June 12th, for his right elbow. More formally known as ulnar collateral ligament (UCL) reconstruction, this surgery is used to repair a torn ulnar collateral ligament inside the elbow. 

The procedure which was performed by Rangers team physician Dr. Keith Meister went well. However, this unexpected development has raised concerns about deGrom's future in the game, with fans and experts eagerly awaiting updates on his recovery and expected timeline for return.

Jacob deGrom's tenure with the New York Mets was marred by injury troubles in the past two seasons. But despite his injury history, deGrom's talent and potential were too enticing to pass up. The Texas Rangers signed him to a lucrative $185 million, five-year contract in free agency last winter.

Before the injury, deGrom had showcased his pitching prowess, amassing a 2-0 record with a commendable 2.67 ERA. The AL West-leading Rangers won all six games in which the two-time National League Cy Young Award winner started, making his absence a significant blow to the team's aspirations.

The decision for deGrom to undergo elbow surgery was necessitated by the discovery of inflammation and significant structural damage in his UCL during an MRI scan. 

This is not deGrom's first encounter with Tommy John surgery, having undergone the procedure earlier in his career while still in the minor leagues. Following that setback, deGrom successfully battled his way back to the majors and emerged as one of the game's premier pitchers. The recent surgery, expected to keep him out for at least a year, triggers a conditional option in deGrom's contract, potentially extending his deal with the Rangers for a sixth season.

It has cast a shadow over his promising tenure with the Texas Rangers. Fans and experts alike are anxiously waiting for updates on his recovery progress and the anticipated timeline for his return to the mound. While the surgery has been deemed successful, the road to full recovery will be a long and arduous one for deGrom.

He will most likely not pitch again in the majors until the end of next season (or longer). Given his age and history, he might not be back until 2025.

The Rangers will undoubtedly miss deGrom's contributions on the field, but the hope remains that he will make a triumphant comeback, armed with his unparalleled talent and determination to overcome adversity. As the baseball world holds its breath, the focus now shifts to supporting deGrom during his rehabilitation journey and eagerly awaiting his triumphant return to the game he loves.